Skip to content

Datacapt vs uMotif

Datacapt logo

Datacapt

Your Clinical Research. Better. Smarter, faster clinical data management for modern trials

23 employees · est. 2019 · Lyon, France

VS
uMotif logo

uMotif

Engaged Patients. Better Trials

82 employees · est. 2012 · London, United Kingdom

uMotif is the older company (2019 vs 2012); uMotif is the larger of the two.

Side-by-Side Comparison

Datacapt uMotif
Founded
2019 2012 older
Headquarters
Lyon, France London, United Kingdom
Employees
23 82 larger
Industry
Data Analytics, Digital Health, Health Care Data Analytics, Health Care, IT
Funding Stage
Pre-Seed Series B
Total Funding
$774.00K $28.73M
Funding Rounds
1 7
Services
Clinical Data Management, Electronic Data Capture, Patient Recruitment and Enrollment, Trial Supply Management, Randomization, eConsent Management, Study Scheduling and Management Development and provision of eCOA/ePRO platforms for clinical and real-world research
Target Customers
Contract Research Organizations (CROs), Pharmaceutical Companies, Biotech Firms, Medical Device Manufacturers, Academic Research Institutions, Consumer Health Companies Clinical research organizations, pharmaceutical companies, academic research institutions
Taxonomy
EClinical SolutionsClinical Data ManagementElectronic Data CaptureDecentralized Clinical TrialsPharmaceutical ResearchBiotech Research +8 EClinical PlatformPatient-centeredClinical ResearchReal-world StudiesEPROECOA +5
Website
datacapt.com umotif.com
Datacapt logo

About Datacapt

Datacapt, founded in 2019, is a French-based innovator in the eClinical and clinical data management space. With its slogan, "Your Clinical Research. Better.", the company promises smarter and faster data management for contemporary trials, tailoring innovative solutions for the clinical research in...

uMotif logo

About uMotif

is a UK-based startup founded in 2012 with a mission to prioritize patients in clinical research. The company's patient-first eClinical platform, designed in collaboration with patients and healthcare professionals, facilitates site-based to fully decentralized clinical, real-world, and post-market...

Also comparing in this category

Comparing more than these two?

Get Datacapt, uMotif and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Datacapt compare?

A PDF of Datacapt and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Datacapt was founded in 2019, based in Lyon, France, with 23 employees. Datacapt, founded in 2019, is a French-based innovator in the eClinical and clinical data management space. With its slogan, "Your Clinical Research. Better.", the company promises smarter and faster. uMotif was founded in 2012, based in London, United Kingdom, with 82 employees. is a UK-based startup founded in 2012 with a mission to prioritize patients in clinical research. The company's patient-first eClinical platform, designed in collaboration with patients and healthcare.
Datacapt has raised $774.00K and uMotif $28.73M. Latest stage: Datacapt Pre-Seed, uMotif Series B.
Both work in Data Analytics and Health Care and list ecoa and epro among their focus areas.

Compare Datacapt with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Datacapt on 2 Apr 2026, and uMotif on 24 Feb 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout